Claire M de la Calle

6PUBLICATIONS
45CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 02, 2026
Germline CDK12 variants in aggressive prostate cancer.

|Dec 15, 2025
Prostate cancer molecular subtypes in systematic versus MRI-targeted biopsy cores at active surveillance: association of PTEN and ERG status with extreme grade reclassification.

Claire M de la Calle, Oluwademilade O Dairo, Zhuo Tony Su

|Sep 28, 2022
The endoplasmic reticulum stress response in prostate cancer.

Claire M de la Calle, Kevin Shee, Heiko Yang

|Sep 08, 2022
Clinical Significance of Perineural Invasion in Men With Grade Group 1 Prostate Cancer on Active Surveillance.

Claire M de la Calle, Mufaddal M Mamawala, Patricia Landis

|Oct 25, 2021
Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy. Letter.

Claire M de la Calle, Sunil H Patel, Max Kates

|Aug 02, 2020
Bladder cancer in patients younger than 40 years: outcomes from the National Cancer Database.

Claire M de la Calle, Samuel L Washington, Peter E Lonergan

Pageof 1

Frequent Collaborators

2 joint publications

Peter E Lonergan

1 joint publications

Samuel L Washington

1 joint publications

Sima P Porten

1 joint publications

Kevin Shee